iPrEx OLE, the open-label extension of the iPrEx study of pre-exposure prophylaxis (PrEP), reported its main findings this week at the 20th International AIDS Conference in Melbourne, Australia, published simultaneously in The Lancet Infectious Diseases. Overall PrEP effectiveness was 50% overall, but 100% in those taking 4 or more doses per week. There was a substantial early drop-out rate, especially among young people.
Progress along the multi-pronged path towards a cure for HIV was one of the themes at the 20th International AIDS Conference (AIDS 2014), taking place this week in Melbourne. Researchers provided updates on the "Mississippi Baby," a novel assay for detecting low levels of hidden virus in the body, and using the anti-cancer drug romidepsin to reactivate latent virus.
Sex workers from more than 30 countries came together this week at the Sex Worker Pre-Conference preceding the 20th International AIDS Conference in Melbourne to consider proposed changes to policy and funding approaches aimed at positioning human rights as critical to the response to HIV/AIDS.
The 20th International AIDS Conference (AIDS 2014) kicked off Sunday in Melbourne, Australia. With the theme of "Stepping Up the Pace" in the response to HIV/AIDS, delegates will focus on expanded access to HIV and hepatitis C treatment, the promise of biomedical prevention, ending criminalization of people with HIV, and reaching key populations including gay men, transgender people, sex workers, prisoners, and people who use drugs.